A blood-based DNA methylation biomarker can track long-term arsenic exposure and predict toxicity risk, offering a non-invasive screening tool for over 200 million people.
Scientists discovered a blood-based DNA marker that tracks arsenic exposure and may predict toxicity risk, offering a new tool for the over 200 million people exposed globally.
A guide to scaling bespoke genetic therapies, based on the story of Mila and the lessons from EveryONE Medicines, covering prerequisites, step-by-step development, and common pitfalls.
Understand FDA’s PFAS findings in baby formula: levels are extremely low (≤2.9 ppt), supply is safe. Steps to reduce exposure and common misconceptions explained.
Learn how historical inequities and modern barriers exclude people of color from psychedelic therapy, and discover actionable steps to advocate for inclusion.
A step-by-step tutorial on obtaining FDA approval for Alzheimer's agitation drugs, using Axsome's recent milestone as a case study. Covers prerequisites, trial phases, regulatory interactions, and common mistakes.
Learn how to effectively read, react, and submit Letters to the Editor to STAT's First Opinion platform, with step-by-step tips and common pitfalls to avoid.
Expert guide to the 5th Circuit's ruling blocking mailing of mifepristone. Covers overview, prerequisites, step-by-step analysis, common mistakes, and summary.
Scientists discover rare flavoalkaloids in cannabis leaves with potential health benefits, challenging previous assumptions about the plant's waste products.
New DNA-based therapy blocks PCSK9 protein, cutting LDL cholesterol nearly 50% without statins, offering breakthrough alternative for heart disease prevention.
New study reveals abdominal muscle movements trigger brain sway that boosts cerebrospinal fluid circulation, potentially flushing out waste linked to Alzheimer’s.
Scientists warn that deadly amoebas are spreading globally due to climate change and outdated water systems. Urgent surveillance and improved treatment are needed to prevent rising infections.
Five research-backed strategies to stay professional during personal crises, based on a therapist's real experience of returning to work after losing her husband.
Key takeaways from a conversation with Kent Beck and reflections on the programmer's virtue of laziness in the age of AI.
Julia Vitarello, whose daughter Mila received a bespoke medicine, is starting a new biotech to produce individualized therapies at scale after her previous company folded due to insufficient FDA guidance.
FDA test of 312 formula samples found PFOS in half, but 95% had under 2.9 ppt. Overall safe, but experts suggest steps to reduce exposure.
As psychedelic therapies gain mainstream support, communities of color face barriers in access, research representation, and cultural inclusion.
PFAS 'forever chemicals' persist in some infant formulas despite low levels. Parents can reduce exposure through breastfeeding, liquid formulas, and questioning manufacturers. Regulators and industry are taking steps to monitor and cut contamination.
FDA proposes excluding semaglutide and tirzepatide from compounding list, while naming Katherine Szarama as acting CBER director, replacing Vinay Prasad.
A synthesis of STAT reader letters on MAHA activism, perimenopause care gaps, and diversity in medical education, highlighting key tensions and actionable solutions.